SKI Market

Indian Indices

Sensex

77,566.16 -1,352.74
( -1.71%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter

Nov 06,2025

Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	979.94	1010.77	-3
OPM %	34.26	31.83	-
PBDT	368.79	355.98	4
PBT	351.36	339.12	4
NP	257.49	252.50	2

77,566.16 -1,352.74 ( -1.71%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

52,808.52 -2,812.32 (-5.06%)

10,249.54 -35.21 (-0.34%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)